Risk of COPD Exacerbations Associated with Statins versus Fibrates: A New User, Active Comparison, and High-Dimensional Propensity Score Matched Cohort Study.
Shu-Hui SunChia-Hsuin ChangZhe-Wei ZhanWen-Hsuan ChangYu-An ChenYaa-Hui DongPublished in: International journal of chronic obstructive pulmonary disease (2021)
This large-scale, population-based cohort study did not show that use of statins was associated with a reduced risk of acute exacerbations in patients with COPD using state-of-the-art pharmacoepidemiologic approaches. The findings emphasize the importance of applying appropriate methodology in exploring statin effectiveness in real-world settings.
Keyphrases
- chronic obstructive pulmonary disease
- cardiovascular disease
- lung function
- liver failure
- cystic fibrosis
- randomized controlled trial
- systematic review
- coronary artery disease
- drug induced
- aortic dissection
- intensive care unit
- hepatitis b virus
- air pollution
- low density lipoprotein
- acute respiratory distress syndrome